menu search

Calidi biotherapeutics announces commitment of $25 million in series b funding to advance stem cell-based platforms for the delivery and potentiation of oncolytic viruses to treat cancer

Financing led by Jackson Investment Group (JIG) with participation from Calidi Cure, LLC, a consortium of new and existing investors led by Allan Cama...

June 23, 2023, 9:00 am


Search within

Pages Search Results: